Dhara Rail Projects Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dhara Rail Projects Ltd is ₹ 125 as of 23 Oct 15:30 . The P/E Ratio of Dhara Rail Projects Ltd changed from 8.8 on March 2026 to 8.8 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Dhara Rail Projects Ltd changed from ₹ 135.83 crore on March 2026 to ₹ 135.83 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The Dividend Payout of Dhara Rail Projects Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Dhara Rail Projects Ltd

Dhara Rail Projects Limited was originally incorporated as Private Limited Company dated April 05, 2010 with the Registrar of Companies, Mumbai.
Thereafter, Company got the status converted into a Public Limited Company via fresh Certificate of Incorporation dated August 25, 2025 changing the name of Company to 'Dhara Rail Projects Limited'. Post incorporation, Company acquired the running business of M/s Dhara Industries as a going concern basis through a Business Purchase Agreement dated July 21, 2010.
Jagruti Tejas Mehta was the proprietor of M/s Dhara Industries which was engaged in the business of executing engineering power infrastructure contracts, mainly with Indian Railways, including Trading and supplying of the required material for the contract and also executing the maintenance contracts.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Dhara Rail Projects Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Dhara Rail Projects Ltd or Sheel Biotech Ltd?

Market cap of Dhara Rail Projects Ltd is 188 Cr while Market cap of Sheel Biotech Ltd is 119 Cr

What are the key factors driving the stock performance of Dhara Rail Projects Ltd and Sheel Biotech Ltd?

The stock performance of Dhara Rail Projects Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dhara Rail Projects Ltd and Sheel Biotech Ltd?

As of October 25, 2026, the Dhara Rail Projects Ltd stock price is INR ₹125.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹58.95.

How do dividend payouts of Dhara Rail Projects Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Dhara Rail Projects Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.